Cargando…

Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review

OBJECTIVES: The main objective of this systematic review was to examine the literature evaluating association of image-based body composition with chemotherapy-related toxicity in ovarian cancer patients. A secondary objective was to evaluate the different definitions of sarcopenia across studies. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzo, Stefania, Raia, Giorgio, Del Grande, Maria, Gasparri, Maria Luisa, Colombo, Ilaria, Manganaro, Lucia, Papadia, Andrea, Del Grande, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667042/
https://www.ncbi.nlm.nih.gov/pubmed/36408182
http://dx.doi.org/10.3389/fonc.2022.1057631
_version_ 1784831641457262592
author Rizzo, Stefania
Raia, Giorgio
Del Grande, Maria
Gasparri, Maria Luisa
Colombo, Ilaria
Manganaro, Lucia
Papadia, Andrea
Del Grande, Filippo
author_facet Rizzo, Stefania
Raia, Giorgio
Del Grande, Maria
Gasparri, Maria Luisa
Colombo, Ilaria
Manganaro, Lucia
Papadia, Andrea
Del Grande, Filippo
author_sort Rizzo, Stefania
collection PubMed
description OBJECTIVES: The main objective of this systematic review was to examine the literature evaluating association of image-based body composition with chemotherapy-related toxicity in ovarian cancer patients. A secondary objective was to evaluate the different definitions of sarcopenia across studies. METHODS: This systematic review was conducted according to the PRISMA-DTA statement and the protocol was registered on Prospero. A comprehensive literature search of 3 electronic databases was performed by two authors. For each eligible article, information was collected concerning the clinical setting; basic study data; population characteristics; technical aspects; body composition features; chemotherapy drugs administered; association of body composition values and toxicities. The overall quality of the included studies was critically evaluated. RESULTS: After the initial retrieval of 812 articles, the systematic review included 6 articles (5/6 studies were retrospective; one was prospective). The number of patients ranged between 69 and 239; mean/median age ranged between 55 and 65 years; the percentage of sarcopenic patients ranged between 25% and 54%. The cut-off values to define sarcopenia and the vertebral levels for evaluation of body composition were different. Five studies included chemotherapy based on carboplatin and paclitaxel, 1 included chemotherapy based on pegylated liposomal doxorubicin. Among the studies including carboplatin and paclitaxel, 3/5 demonstrated an association with toxicity, whereas 2/5 did not. Altogether, 4/6 papers demonstrated an association between the body composition values and the development of chemotherapy-related toxicities. CONCLUSIONS: There is a wide variability of results about the association of body composition and chemotherapy-related toxicity in ovarian cancer patients. Therefore further studies, possibly including a comprehensive assessment of body compartments and where the definition of body composition cut-offs is constant, are warranted to better understand this association. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022337753, identifier (CRD42022337753).
format Online
Article
Text
id pubmed-9667042
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96670422022-11-17 Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review Rizzo, Stefania Raia, Giorgio Del Grande, Maria Gasparri, Maria Luisa Colombo, Ilaria Manganaro, Lucia Papadia, Andrea Del Grande, Filippo Front Oncol Oncology OBJECTIVES: The main objective of this systematic review was to examine the literature evaluating association of image-based body composition with chemotherapy-related toxicity in ovarian cancer patients. A secondary objective was to evaluate the different definitions of sarcopenia across studies. METHODS: This systematic review was conducted according to the PRISMA-DTA statement and the protocol was registered on Prospero. A comprehensive literature search of 3 electronic databases was performed by two authors. For each eligible article, information was collected concerning the clinical setting; basic study data; population characteristics; technical aspects; body composition features; chemotherapy drugs administered; association of body composition values and toxicities. The overall quality of the included studies was critically evaluated. RESULTS: After the initial retrieval of 812 articles, the systematic review included 6 articles (5/6 studies were retrospective; one was prospective). The number of patients ranged between 69 and 239; mean/median age ranged between 55 and 65 years; the percentage of sarcopenic patients ranged between 25% and 54%. The cut-off values to define sarcopenia and the vertebral levels for evaluation of body composition were different. Five studies included chemotherapy based on carboplatin and paclitaxel, 1 included chemotherapy based on pegylated liposomal doxorubicin. Among the studies including carboplatin and paclitaxel, 3/5 demonstrated an association with toxicity, whereas 2/5 did not. Altogether, 4/6 papers demonstrated an association between the body composition values and the development of chemotherapy-related toxicities. CONCLUSIONS: There is a wide variability of results about the association of body composition and chemotherapy-related toxicity in ovarian cancer patients. Therefore further studies, possibly including a comprehensive assessment of body compartments and where the definition of body composition cut-offs is constant, are warranted to better understand this association. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022337753, identifier (CRD42022337753). Frontiers Media S.A. 2022-11-02 /pmc/articles/PMC9667042/ /pubmed/36408182 http://dx.doi.org/10.3389/fonc.2022.1057631 Text en Copyright © 2022 Rizzo, Raia, Del Grande, Gasparri, Colombo, Manganaro, Papadia and Del Grande https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Rizzo, Stefania
Raia, Giorgio
Del Grande, Maria
Gasparri, Maria Luisa
Colombo, Ilaria
Manganaro, Lucia
Papadia, Andrea
Del Grande, Filippo
Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review
title Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review
title_full Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review
title_fullStr Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review
title_full_unstemmed Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review
title_short Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review
title_sort body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: a systematic review
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667042/
https://www.ncbi.nlm.nih.gov/pubmed/36408182
http://dx.doi.org/10.3389/fonc.2022.1057631
work_keys_str_mv AT rizzostefania bodycompositionasapredictorofchemotherapyrelatedtoxicityinovariancancerpatientsasystematicreview
AT raiagiorgio bodycompositionasapredictorofchemotherapyrelatedtoxicityinovariancancerpatientsasystematicreview
AT delgrandemaria bodycompositionasapredictorofchemotherapyrelatedtoxicityinovariancancerpatientsasystematicreview
AT gasparrimarialuisa bodycompositionasapredictorofchemotherapyrelatedtoxicityinovariancancerpatientsasystematicreview
AT colomboilaria bodycompositionasapredictorofchemotherapyrelatedtoxicityinovariancancerpatientsasystematicreview
AT manganarolucia bodycompositionasapredictorofchemotherapyrelatedtoxicityinovariancancerpatientsasystematicreview
AT papadiaandrea bodycompositionasapredictorofchemotherapyrelatedtoxicityinovariancancerpatientsasystematicreview
AT delgrandefilippo bodycompositionasapredictorofchemotherapyrelatedtoxicityinovariancancerpatientsasystematicreview